Me neither @dyeman, it took me a while to accumulate & happy with my holding here as I am with management to run this company well as they have been since I bought in July last year.
Going into a 2b you have to be prepared to wait out the trial, be forward looking & treat this as a medium to long term investment. If we get something in the near future, you just never know. Rare diseases are on the radar (FSGS) as are chronic health conditions (CKD & DM), we aren’t at the mercy of Big Pharma though. btw great post @dyeman
Ann: Ceasing to be a substantial holder, page-76
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.025(6.67%) |
Mkt cap ! $25.68M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 35.0¢ | $387.8K | 1.079M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 394907 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 15948 | 1 |
View Market Depth
| Last trade - 16.10pm 12/12/2024 (20 minute delay) ? |
| DXB (ASX) Chart |